Erratum. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S158-S190.
作者信息
ElSayed Nuha A, Aleppo Grazia, Aroda Vanita R, Bannuru Raveendhara R, Brown Florence M, Bruemmer Dennis, Collins Billy S, Das Sandeep R, Hilliard Marisa E, Isaacs Diana, Johnson Eric L, Kahan Scott, Khunti Kamlesh, Kosiborod Mikhail, Leon Jose, Lyons Sarah K, Perry Mary Lou, Prahalad Priya, Pratley Richard E, Seley Jane Jeffrie, Stanton Robert C, Gabbay Robert A
出版信息
Diabetes Care. 2023 Apr 1;46(4):898. doi: 10.2337/dc23-er04.
Abstract
摘要
相似文献
1
Erratum. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S158-S190.
Diabetes Care. 2023 Apr 1;46(4):898. doi: 10.2337/dc23-er04.
2
Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care 2024;47(Suppl. 1):S158-S178.
Diabetes Care. 2024 Jul 1;47(7):1238. doi: 10.2337/dc24-er07a.
3
Erratum. 10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S144-S174.
Diabetes Care. 2022 May 1;45(5):1296. doi: 10.2337/dc22-er05.
4
Erratum. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1): S175-S184.
Diabetes Care. 2022 Mar 1;45(3):758. doi: 10.2337/dc22-er03.
5
Erratum. Diabetes Care in the Hospital. Sec. 14. In . Diabetes Care 2017;40(Suppl. 1);S120-S127.
Diabetes Care. 2017 Jul;40(7):986. doi: 10.2337/dc17-er07d. Epub 2017 May 18.
6
Erratum. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
Diabetes Care. 2023 May 1;46(5):1106. doi: 10.2337/dc23-er05.
7
Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S13-S22.
Diabetes Care. 2016 Sep;39(9):1653. doi: 10.2337/dc16-er09.
8
Erratum. Microvascular Complications and Foot Care. Sec. 10. In . Diabetes Care 2017;40(Suppl. 1);S88-S98.
Diabetes Care. 2017 Jul;40(7):986. doi: 10.2337/dc17-er07c. Epub 2017 May 18.
9
Erratum. Glycemic Targets. Sec. 6. In . Diabetes Care 2017;40(Suppl. 1);S48-S56.
Diabetes Care. 2017 Jul;40(7):985. doi: 10.2337/dc17-er07a. Epub 2017 May 18.
10
Addendum. 10. Cardiovascular Disease and Risk Management: . Diabetes Care 2020;43(Suppl. 1):S111-S134.
Diabetes Care. 2020 Aug;43(8):1977-1978. doi: 10.2337/dc20-ad08. Epub 2020 Jun 5.
引用本文的文献
1
Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials.
Eur J Med Res. 2025 Jan 7;30(1):13. doi: 10.1186/s40001-024-02241-4.
2
Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study.
Cardiovasc Diabetol. 2024 Aug 12;23(1):297. doi: 10.1186/s12933-024-02391-z.
Zotero 插件